Suppr超能文献

代谢型谷氨酸受体参与麻醉大鼠延髓水平的呼吸控制。

Metabotropic glutamate receptors are involved in the control of breathing at the medulla oblongata level of anaesthetized rats.

作者信息

Vitagliano S, Berrino L, Pizzirusso A, D'Amico M, Calderaro V, Maione S, Rossi F

机构信息

Institute of Pharmacology and Toxicology, Faculty of Medicine and Surgery, II University of Naples, Italy.

出版信息

Neuropharmacology. 1994 Jul;33(7):859-64. doi: 10.1016/0028-3908(94)90182-1.

Abstract

The goal of the present study was to identify sites in the medulla oblongata where metabotropic glutamate receptors are involved in regulating respiration. Unilateral microinjections (50 nl) of L-glutamate (L-glu) (10-25-50 mM) into the nucleus tractus solitarii (NTS) of anaesthetized rats elicited apnea (8.6 +/- 0.3 sec; 21.3 +/- 3.6 sec; 66.3 +/- 16.5 sec respectively; N = 6) and arterial hypotension (7.3 +/- 2.4 mmHg; 10.1 +/- 2.3 mmHg; 35.3 +/- 7.5 mmHg respectively; N = 6). Similarly, in other rats 1-aminocyclopentane-1, 3-dicarboxylic acid (ACPD) (1-5-10 mM), a selective agonist of metabotrophic glutamate receptors, also induced apnea (22.4 +/- 2.5 sec; 32.5 +/- sec; 92.5 +/- 1.4 sec respectively; N = 6) and arterial hypotension (12.7 +/- 2.2 mmHg; 19.6 +/- 4.3 mmHg; 26.5 +/- 1.5 mmHg respectively; N = 6). Paired experiments showed that unilateral microinjections of L-glu (50 mM) and ACPD (1 mM) into the nucleus retroambigualis (NRA) of anaesthetized rats elicited apnea (20.2 +/- 2.6 sec and 33.8 +/- 3.2 sec respectively; N = 6) and arterial hypotension (15.7 +/- 3.7 mmHg and 22.5 +/- 4.5 mmHg respectively; N = 6). The ACPD effects on apnea and hypotension in NTS and NRA were not prevented by a 3 min pretreatment with L-AP3 (30 mM), a putative antagonist of metabotropic glutamate receptors (19.5 +/- 1.4 sec; 12.3 +/- 3.2 mmHg and 30.6 +/- 2.9 sec; 23.4 +/- 3.8 mmHg respectively; N = 6). These data suggest that metabotropic glutamate receptors are involved in NTS and NRA regulation of cardiorespiratory functions.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究的目的是确定延髓中代谢型谷氨酸受体参与调节呼吸的部位。向麻醉大鼠的孤束核(NTS)单侧微量注射(50 nl)L-谷氨酸(L- glu)(10 - 25 - 50 mM)会引发呼吸暂停(分别为8.6±0.3秒;21.3±3.6秒;66.3±16.5秒;N = 6)和动脉低血压(分别为7.3±2.4 mmHg;10.1±2.3 mmHg;35.3±7.5 mmHg;N = 6)。同样,在其他大鼠中,代谢型谷氨酸受体的选择性激动剂1-氨基环戊烷-1,3-二羧酸(ACPD)(1 - 5 - 10 mM)也会引发呼吸暂停(分别为22.4±2.5秒;32.5±秒;92.5±1.4秒;N = 6)和动脉低血压(分别为12.7±2.2 mmHg;19.6±4.3 mmHg;26.5±1.5 mmHg;N = 6)。配对实验表明,向麻醉大鼠的疑后核(NRA)单侧微量注射L- glu(50 mM)和ACPD(1 mM)会引发呼吸暂停(分别为20.2±2.6秒和33.8±3.2秒;N = 6)和动脉低血压(分别为15.7±3.7 mmHg和22.5±4.5 mmHg;N = 6)。用代谢型谷氨酸受体的假定拮抗剂L-AP3(30 mM)预处理3分钟并不能阻止ACPD对NTS和NRA中呼吸暂停和低血压的影响(分别为19.5±1.4秒;12.3±3.2 mmHg和30.6±2.9秒;23.4±3.8 mmHg;N = 6)。这些数据表明,代谢型谷氨酸受体参与NTS和NRA对心肺功能的调节。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验